Physician profile
Thomas C Hwang
NPI 1124039722
$2,190.15
in general payments reported to CMS, 2019-2025
21 companies · $464 in 2025
The $464 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $91.02 · 2020: $28.81 · 2021: $207 · 2022: $408 · 2023: $549 · 2024: $442 · 2025: $464.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,455.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,455.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $486.47 | 2021-2025 | Jardiance |
| Lilly USA, LLC | $346.26 | 2022-2025 | Mounjaro, Zepbound, Trulicity |
| Astrazeneca Pharmaceuticals LP | $251.28 | 2019-2025 | Airsupra, Breztri, Farxiga |
| Merck Sharp & Dohme LLC | $172.94 | 2021-2025 | Capvaxive, Gardasil 9, Belsomra |
| Horizon Therapeutics Plc | $153.38 | 2021-2023 | Uplizna, Krystexxa |
| Pfizer INC. | $135.33 | 2020-2025 | |
| Exact Sciences Corporation | $99.75 | 2023-2025 | Cologuard Collection Kit |
| Janssen Pharmaceuticals, INC | $98.93 | 2024-2025 | Spravato |
| Glaxosmithkline, LLC. | $87.83 | 2023-2025 | Arexvy, Shingrix, Trelegy Ellipta |
| Medtronic, INC. | $68.35 | 2023 | Auto Suture |
| Amgen INC. | $59.94 | 2019-2025 | Repatha |
| Edwards Lifesciences Corporation | $44.41 | 2023 | Edwards Sapien 3 Ultra Transcatheter Heart Valve, Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Idorsia Pharmaceuticals US INC | $34.42 | 2023 | Quviviq |
| Novartis Pharmaceuticals Corporation | $28.66 | 2025 | |
| Novo Nordisk INC | $24.45 | 2023 | Rybelsus, Ozempic |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch Health US, LLC | $23.47 | 2024 | Wellbutrin |
| Sanofi Pasteur INC. | $19.61 | 2025 | |
| Therapeuticsmd, INC. | $14.64 | 2020 | |
| Shield Therapeutics INC | $14.17 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $13.05 | 2019 | |
| Amarin Pharma, INC. | $12.81 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Hwang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.